About Cellda
Cellda is a Healthcare company based in Uppsala (Sweden) founded in 2018. It develops software tools for accurate prostate cancer diagnosis and analysis. It operates on a B2B model. Cellda offers products and services including Cellda® Image Analysis Suite and Cellda® Prostate. Its focus areas include Diagnostics Tech, Cancer Diagnostics, Prostate Cancer and Biotech. Its legal entity is Cellda AB. Its competitors include Pictor Labs, BioImagene, Exact Imaging, Leica Biosystems and Aquyre and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Cellda AB, based in Uppsala, Sweden, focuses on advancing cancer diagnostics through innovative image analysis technology. Their products, like the Cellda Image Analysis Suite and Cellda Prostate, provide faster and more objective results for healthcare providers. The company engages in research, grants, and investments to improve patient care and outcomes in oncology, emphasizing reliable diagnostic tools without promotional claims.
- Headquarters Uppsala, Sweden
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cellda.com
- Social LinkedIn
- Legal Name Cellda Ab
Products & Services of Cellda
Cellda offers a comprehensive portfolio of products and services, including Cellda® Image Analysis Suite and Cellda® Prostate.
Offers image processing for accurate cancer diagnosis in healthcare.
Provides specialized analysis for detecting prostate cancer effectively.
Competitors of Cellda
Cellda has 9 listed competitors in our database, 7 of them funded. They include Pictor Labs, BioImagene, Exact Imaging, Leica Biosystems and Aquyre, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pictorlabs.ai | 2019 | Los Angeles, United States | $48.83M | – | AI-based tools for pathological image analysis are provided to labs. | |
| bioimagene.com | 2003 | Sunnyvale, United States | $40.2M | 40 | Digital pathology tools are developed for diagnostics and drug discovery. | |
| exactimaging.com | 2013 | Markham, Canada | $29.91M | 26 | Micro-ultrasound devices for prostate imaging and biopsies are developed. | |
| leicabiosystems.com | 1989 | Nussloch, Germany | – | 365 | Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide. | |
| aquyre.com | 2007 | Weston, United States | $28.59M | – | Cellular-level optical biopsy imaging systems are developed for tissue analysis. | |
| hema.to | 2019 | Munich, Germany | $7.7M | – | SaaS and AI-based software for leukemia diagnosis is developed. | |
| imagistxprostate.com | 2003 | Las Vegas, United States | $4.2M | – | Prostate cancer imaging is enabled by micro-ultrasound technology. | |
| koelis.com | 2006 | Meylan, France | – | – | MRI/ultrasound fusion biopsy systems for prostate care are developed. | |
| triopsy.com | 2012 | Aurora, United States | $4.14M | – | Medical device for precise prostate cancer diagnosis is developed. |
Detailed competitors of Cellda
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
10 companies that operate in the same segment as Cellda (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | – | 336 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cellda
Cellda was founded in 2018.
Cellda is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
Cellda AB, based in Uppsala, Sweden, focuses on advancing cancer diagnostics through innovative image analysis technology. Their products, like the Cellda Image Analysis Suite and Cellda Prostate, provide faster and more objective results for healthcare providers. The company engages in research, grants, and investments to improve patient care and outcomes in oncology, emphasizing reliable diagnostic tools without promotional claims.
Cellda's top competitors include Pictor Labs, BioImagene and Hema.to.
Cellda offers Cellda® Image Analysis Suite and Cellda® Prostate.
Cellda operates through Cellda Ab.